TY - JOUR AU - Meaney-Delman, Dana AU - Zotti, Marianne AU - Creanga, Andreea AU - Misegades, Lara AU - Wako, Etobssie AU - Treadwell, Tracee AU - Messonnier, Nancy AU - Jamieson, Denise T1 - Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women T2 - Emerging Infectious Disease journal PY - 2014 VL - 20 IS - 2 SN - 1080-6059 AB - In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measures, and communication. The purpose of this meeting summary is to provide updated clinical information to health care providers and public health professionals caring for P/PP/L women in the setting of a bioterrorist event involving anthrax. KW - Bacillus anthracis KW - anthrax KW - antibacterial agents KW - antimicrobial drugs KW - pregnancy KW - postpartum period KW - lactation KW - breast feeding KW - bacteria KW - women KW - breast-feeding KW - treatment KW - antibiotics KW - antitoxins KW - PEP KW - postexposure prophylaxis KW - vaccine KW - vaccination DO - 10.3201/eid2002.130611 UR - https://wwwnc.cdc.gov/eid/article/20/2/13-0611_article ER - End of Reference